Cargando…
Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors
Telomerase reverse transcriptase (TERT) mutation is the most frequent genetic alteration in hepatocellular carcinoma (HCC). Our aims were to investigate whether TERT mutations can be detected in circulating cell‐free DNA (cfDNA) of patients with HCC and/or cirrhosis and characterize clinical paramet...
Autores principales: | Jiao, Jingjing, Watt, Gordon P., Stevenson, Heather L., Calderone, Tiffany L., Fisher‐Hoch, Susan P., Ye, Yuanqing, Wu, Xifeng, Vierling, John M., Beretta, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983165/ https://www.ncbi.nlm.nih.gov/pubmed/29881823 http://dx.doi.org/10.1002/hep4.1187 |
Ejemplares similares
-
Telomerase reverse transcriptase and neurodegenerative diseases
por: Yu, Xin, et al.
Publicado: (2023) -
Telomerase reverse transcriptase moonlights: Therapeutic targets beyond telomerase
por: Maida, Yoshiko, et al.
Publicado: (2015) -
Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
por: Toshikuni, N, et al.
Publicado: (2000) -
The Emerging Role of Telomerase Reverse Transcriptase in Mitochondrial DNA Metabolism
por: Gordon, Donna M., et al.
Publicado: (2010) -
Telomerase reverse transcriptase in the regulation of gene expression
por: Zhou, Junzhi, et al.
Publicado: (2014)